Literature DB >> 33792899

Glucagon's Metabolic Action in Health and Disease.

Anja Zeigerer1,2, Revathi Sekar1,2, Maximilian Kleinert2,3,4, Shelly Nason5, Kirk M Habegger5, Timo D Müller2,3,6.   

Abstract

Discovered almost simultaneously with insulin, glucagon is a pleiotropic hormone with metabolic action that goes far beyond its classical role to increase blood glucose. Albeit best known for its ability to directly act on the liver to increase de novo glucose production and to inhibit glycogen breakdown, glucagon lowers body weight by decreasing food intake and by increasing metabolic rate. Glucagon further promotes lipolysis and lipid oxidation and has positive chronotropic and inotropic effects in the heart. Interestingly, recent decades have witnessed a remarkable renaissance of glucagon's biology with the acknowledgment that glucagon has pharmacological value beyond its classical use as rescue medication to treat severe hypoglycemia. In this article, we summarize the multifaceted nature of glucagon with a special focus on its hepatic action and discuss the pharmacological potential of either agonizing or antagonizing the glucagon receptor for health and disease. © 2021 American Physiological Society. Compr Physiol 11:1759-1783, 2021.
Copyright © 2021 American Physiological Society. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33792899      PMCID: PMC8513137          DOI: 10.1002/cphy.c200013

Source DB:  PubMed          Journal:  Compr Physiol        ISSN: 2040-4603            Impact factor:   9.090


  422 in total

1.  The mechanism of satiety: effect of glucagon on gastric hunger contractions in man.

Authors:  A J STUNKARD; T B VAN ITALLIE; B B REIS
Journal:  Proc Soc Exp Biol Med       Date:  1955-06

Review 2.  Glucagonocentric restructuring of diabetes: a pathophysiologic and therapeutic makeover.

Authors:  Roger H Unger; Alan D Cherrington
Journal:  J Clin Invest       Date:  2012-01-03       Impact factor: 14.808

3.  Glucose dependence of the regulated secretory pathway in alphaTC1-6 cells.

Authors:  Rebecca McGirr; Christina E Ejbick; David E Carter; Joseph D Andrews; Ying Nie; Theodore C Friedman; Savita Dhanvantari
Journal:  Endocrinology       Date:  2005-06-30       Impact factor: 4.736

4.  Intra-islet insulin suppresses glucagon release via GABA-GABAA receptor system.

Authors:  Elaine Xu; Mohan Kumar; Yi Zhang; William Ju; Toshiyuki Obata; Nina Zhang; Shiying Liu; Anna Wendt; Shaoping Deng; Yousuke Ebina; Michael B Wheeler; Matthias Braun; Qinghua Wang
Journal:  Cell Metab       Date:  2006-01       Impact factor: 27.287

Review 5.  Glucagon receptors.

Authors:  F Authier; B Desbuquois
Journal:  Cell Mol Life Sci       Date:  2008-06       Impact factor: 9.261

Review 6.  Rab proteins and the compartmentalization of the endosomal system.

Authors:  Angela Wandinger-Ness; Marino Zerial
Journal:  Cold Spring Harb Perspect Biol       Date:  2014-10-23       Impact factor: 10.005

7.  Effects of iodination of tyrosyl residues on the binding and action of glucagon at its receptor.

Authors:  M C Lin; S Nicosia; M Rodbell
Journal:  Biochemistry       Date:  1976-10-05       Impact factor: 3.162

8.  Role of the liver in glucose homeostasis.

Authors:  R S Sherwin
Journal:  Diabetes Care       Date:  1980 Mar-Apr       Impact factor: 19.112

9.  Somatostatin inhibits insulin and glucagon release by monolayer cell cultures of rat endocrine pancreas.

Authors:  W Y Fujimoto; J W Ensinck; R H Williams
Journal:  Life Sci       Date:  1974-12-01       Impact factor: 5.037

10.  Cyclic AMP-dependent protein kinase regulates transcription of the phosphoenolpyruvate carboxykinase gene but not binding of nuclear factors to the cyclic AMP regulatory element.

Authors:  P G Quinn; D K Granner
Journal:  Mol Cell Biol       Date:  1990-07       Impact factor: 4.272

View more
  6 in total

Review 1.  Function of the GABAergic System in Diabetic Encephalopathy.

Authors:  Hongli Zhou; Zhili Rao; Zuo Zhang; Jiyin Zhou
Journal:  Cell Mol Neurobiol       Date:  2022-04-23       Impact factor: 5.046

Review 2.  Endosomal trafficking in metabolic homeostasis and diseases.

Authors:  Jerome Gilleron; Anja Zeigerer
Journal:  Nat Rev Endocrinol       Date:  2022-10-10       Impact factor: 47.564

3.  Cross Talk Between Insulin and Glucagon Receptor Signaling in the Hepatocyte.

Authors:  Kirk M Habegger
Journal:  Diabetes       Date:  2022-09-01       Impact factor: 9.337

4.  Postprandial Dynamics of Proglucagon Cleavage Products and Their Relation to Metabolic Health.

Authors:  Robert Wagner; Sabine S Eckstein; Louise Fritsche; Katsiaryna Prystupa; Sebastian Hörber; Hans-Ulrich Häring; Andreas L Birkenfeld; Andreas Peter; Andreas Fritsche; Martin Heni
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-29       Impact factor: 6.055

Review 5.  Recent Advances in Incretin-Based Pharmacotherapies for the Treatment of Obesity and Diabetes.

Authors:  Qiming Tan; Seun E Akindehin; Camila E Orsso; Richelle C Waldner; Richard D DiMarchi; Timo D Müller; Andrea M Haqq
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-01       Impact factor: 5.555

6.  Organ-Specific Glucose Uptake: Does Sex Matter?

Authors:  Adithi Gandhi; Ryan Tang; Youngho Seo; Aditi Bhargava
Journal:  Cells       Date:  2022-07-16       Impact factor: 7.666

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.